A consortium reports the tripling of the number of genetic markers in Phase II of the International HapMap Project. This map of human genetic variation will continue to revolutionize discovery of susceptibility loci in common genetic diseases, and study of genes under selection in humans.
- Kelly A. Frazer (Principal Investigator)
- Dennis G. Ballinger
- John Stewart